Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model.

Annamalai, Balasubramaniam; Parsons, Nathaniel; Belhaj, Marwa; Brandon, Carlene; Potts, Jay; Rohrer, Bärbel

Annamalai, Balasubramaniam; Parsons, Nathaniel; Belhaj, Marwa; Brandon, Carlene; Potts, Jay; Rohrer, Bärbel.

Afiliação

Annamalai B; Departments of Ophthalmology, Medical University of South Carolina, Charleston, SC, USA.
Parsons N; Departments of Ophthalmology, Medical University of South Carolina, Charleston, SC, USA.
Belhaj M; Department of Cell Biology, University of South Carolina, Columbia, SC, USA.
Brandon C; Departments of Ophthalmology, Medical University of South Carolina, Charleston, SC, USA.
Potts J; Department of Cell Biology, University of South Carolina, Columbia, SC, USA.
Rohrer B; Departments of Ophthalmology, Medical University of South Carolina, Charleston, SC, USA.

Transl Vis Sci Technol ; 7(2): 3, 2018 Mar.

Article em En | MEDLINE | ID: mdl-29576927

Palavras-chave

choroidal neovascularization; complement system; encapsulated ARPE-19 cells; targeted alternative pathway inhibitor CR2-fH

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Transl Vis Sci Technol Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google